Emanuele Mazzola

The role of chemoprevention in modifying the risk of breast cancer in women with atypical breast lesions.

The penetrance of ductal carcinoma in situ among BRCA1 and BRCA2 mutation carriers.

Recent BRCAPRO upgrades significantly improve calibration.

Revisiting the immune microenvironment of diffuse large B-cell lymphoma using a tissue microarray and immunohistochemistry: robust semi-automated analysis reveals CD3 and FoxP3 as potential predictors of response to R-CHOP.

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.

Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia.

Recent Enhancements to the Genetic Risk Prediction Model BRCAPRO.

Inhibitory Effect of Individual or Combinations of Broadly Neutralizing Antibodies and Antiviral Reagents against Cell-Free and Cell-to-Cell HIV-1 Transmission.

Breast Cancer Risk and Follow-up Recommendations for Young Women Diagnosed with Atypical Hyperplasia and Lobular Carcinoma In Situ (LCIS).

Wide Dispersion and Diversity of Clonally Related Inhibitory Interneurons.